WHIS 2026 adds 18 new speakers to October summit agenda

The Women’s Health Innovation Summit (WHIS), the event uniting the global  women’s health ecosystem, has just announced 18 new speakers joining the agenda for  its 2026 summit, taking place October 13–15 at Encore Boston Harbor.

The latest additions bring further depth across pharma, clinical research, health  systems, venture, and policy, reinforcing WHIS’s role as the only platform where the full women’s health ecosystem convenes under one roof.

Newly confirmed speakers include:

• Kelle Moley, MD – VP, Women’s Health Early Phase Clinical Development, Cardiometabolic Research, Eli Lilly & Company
• Justine Levin-Allerhand – Executive Partner, Chief Corporate Development Officer & COO, Flagship Labs, Flagship Pioneering
• Sebnem Yildirimoglu, MD, PMP – Executive Director, Women’s Health Strategy, Premier Research
• Terri Stewart – Head of Global Healthcare & Government Affairs, EMD Serono
• Dr. Morag Grassie – Executive Director, Blavatnik Fund for Innovation, Yale
• Sandra Butler – Director, Design Impact, Mass General Brigham
• Zhenya Lindgardt – Chief Executive Officer, Sera Prognostics
• Sadie Morahan – Head of US Revenue, Withings Health Solutions
• Angela Drew, PhD – Vice President, Regulatory Strategy, Premier Research
• Dr. Stephanie Lahr – CMIO, Aqurio
• Michelle Andrews – Contributing Writer, KFF Health News
• Charlotte Williams – CEO, My Bump Hub
• Clint Dart, MS – Director, NIH Women’s Health Data Coordinating Center, Premier Research
• Cass Sanford – US Venture Advisor, FemTech Lab
• Megan Mukuria – Founder & CEO, ZanaAfrica
• Tiffany Inglis, MD, FACOG – Chief Medical Officer, Sera Prognostics
• Angelean Hendrix, PhD – Vice President, Pharmacometrics and MIDD, Premier Research
• Amanda Ducach – CEO & Co-founder, EmaEQ

“WHIS is where the women’s health industry comes together to take action,” said Poppy Howard-Wall, Event Director at WHIS.

“This latest wave of speakers reflects exactly the kind of cross-sector expertise our attendees expect – from global pharma and clinical research leadership to venture, health systems, and grassroots innovation.

“It’s this breadth that makes WHIS the room where things actually move forward.”

Bringing the Full Ecosystem Together

These additions join a growing 2026 agenda spanning four content tracks that reflect the  full lifecycle of healthcare innovation, from early-stage research and development  through to patient delivery, system transformation, and commercial scale.

Attendees can expect over 1,000 senior decision-makers, 120+ expert speakers, four dedicated stages, and more than 10 hours of curated 1:1 meetings.

Full speaker and agenda details are available at whisusa.com/speakers-2026.

About WHIS

The Women’s Health Innovation Summit is the only platform uniting the full women’s  health ecosystem – providers, payers, employers, pharma leaders, investors, and innovators -to increase deal flow, expand reimbursement, improve access, and deliver better outcomes for women at every stage of life.